Publicaties apr. biol. S. Jonckheere

• Jonckheere S, Dierick J, Vanhouteghem H, Devleeschouwer M, Stove V. Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on Continuous Erythropoietin Receptor Activator versus Epoetin β therapy. Acta Haematol 2010(124):27-33.
• Jonckheere S, De Baere T, Soetens O, De Bel A, Schroeyers P, Surmont I. Prosthetic valve endocarditis caused by Bordetella holmesii, an Acinetobacter look-alike. J Med Microbiol 2012(61):874-877.
• Jonckheere S, Boel A, De Beer T, Van Vaerenbergh K, De Beenhouwer H. Surgical site infections caused by Clostridium perfringens after orthopedic surgery: two case reports with attention to epidemiologic investigation. The Journal of Infect dis 2014(9):177-181.
• Jonckheere S, Berth M, Van Esbroeck M, Blomme S, Lagrou K, Padalko E. Evaluation of different confirmatory algorithms using seven treponemal tests on Architect Syphilis TP positive/RPR negative sera. Eur J Clin Microbiol Infect Dis 2015(34):2041-2048.
• Jonckheere S, Verfaillie C, Boel A, Van Vaerenbergh K, Vankeerberghen A, De Beenhouwer H. Multicenter evaluation of BD Veritor System and RSV K-SeT for rapid detection of respiratory syncytial virus. Diagn Microbiol Infect Dis 2015(83):37-40.
• Jonckheere S, Van Vaerenbergh K, Boel A, Vankeerberghen A, De Beenhouwer H. How is the Xpert MRSA Gen 3 assay (Cepheid) performing on pooled eSwab medium? Diagn Microbiol Infect Dis 2015(83):219-221.
• Criel M^#, Jonckheere S^#, Langlois M. Evaluation of three hemoglobin A1c point-of-care instruments. Clin Lab 2016(62):285-291. ^#These authors contributed equally.
• Colin P, Eleveld D, Jonckheere S, De Waele J, Van Bocxlaer J, Vermeulen A. What about confidence intervals? A word of caution when interpreting Probability of Target Attainment simulations. J Antimicrob Chemother 2016(71):2502-2508.
• Jonckheere S, De Neve N, De Beenhouwer H, Berth M, Vermeulen A, Van Bocxlaer J, Colin P. A model based analysis of the predictive performance of different renal function markers for cefepime in the intensive care unit. J Antimicrob Chemother 2016(71):2538-2546.
• De Keukeleire S, Mathys V, Van den Wijngaert S, Van De Vyvere M, Jonckheere S, De Beenhouwer H, De Bel A, Arrazola de Onate W, Wanlin M, Piérard D, Nulens E, Saegeman V. Nontuberculous Mycobacteria among pulmonary tuberculosis patients: a retrospective Belgian multicenter study. Acta Clin Belg 2016(24):1-4.
• Trouvé C, Blot S, Hayette M-P, Jonckheere S, Patteet S, Rodriguez-Villalobos H, Symoens F, Van Wijngaerden E, Lagrou K. Epidemiology and reporting of candidaemia in Belgium: a multi-centre study. Eur J Clin Microbiol Infect Dis 2017(36):649-655.
• Jonckheere S, Botteldoorn N, Vandecandelaere P, Frans J, Laffut W, Coppens G, Vankeerberghen A, De Beenhouwer H. Multicenter evaluation of the revised RIDA® QUICK test (N1402) for rapid detection of norovirus in a diagnostic laboratory setting. Diagn Microbiol Infect Dis 2017(88):31-35.
• Vankeerberghen A, Jonckheere S, De Raeve H, Caluwe R, Beenhouwer H. A novel Tropheryma species in a lung biopsy of a kidney transplant patient. Clin Microbiol Infect 2018(24):548.
• Colin P, Jonckheere S, Struys M. Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients. Clin Pharmacokinet 2018(57):1435-1447.
• Prudent E, Le Guenno G, Jonckheere S, Lepidi H, Angelakis E, Raoult D. Fluorescent in situ hybridization can be used as a complementary assay for the diagnosis of Tropheryma whipplei infection. Infection 2018(47):317-321.
• Jonckheere S, De Neve N, Verbeke J, De Decker K, Brandt I, Boel A, Van Bocxlaer J, Struys M, Colin P. Target Controlled Infusion of cefepime in critically ill patients: a single center experience. Antimicrob Agents Chemother 2019(64):e01552-19.
• Van Elslande J, Decru B, Jonckheere S, Van Wijngaerden E, Houben E, Vandecandelaere P, Indevuyst C, Depypere M, Desmet S, André E, Van Ranst M, Lagrou K, Vermeersch P. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs. Clin Microbiol Infect 2020(20):30446-8.
• Bauters E, Jonckheere S, Dehaene I, Vandecandelaere P, Angeles Argudín M, Page G. Prevalence and Clinical Relevance of Colonization with Methicillin-Resistant Staphylococcus aureus in the Obstetric Population. J Matern Fetal Neonatal Med 2022(25):8186-8191.
• Cornette M, Decaesteker B, Martens GA, Vandecandelaere P, Jonckheere S. From Delta to Omicron SARS-CoV-2 variant: switch to saliva sampling for higher detection rate. J Clin Virol Plus 2022(3):100090.
• Cuypers L, …, Jonckheere S, et al. Nationwide harmonization effort for semi-quantitative reporting of SARS-CoV-2 PCR test results in Belgium. Viruses 2022(6):1294.
• Callewaert C, …, Jonckheere S, et al. Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat. Front Med (Lausanne) 2023(10):1185779.
• Jonckheere S, Mairesse C, Vandecandelaere P, Vanbiervliet J, Terryn W, Somers J, Prevost B, Martiny D. Campylobacter coli prosthetic joint infection: case report and a review of the literature. Pathogens 2024(10):383.
• Janssens H, Delameillieure L, Jonckheere S, Van Houtte F, Meuleman P, Geens T. Higher hepatitis E seroprevalence in workers in the pig sector in Flanders, Belgium: results from a seroprevalence case-control study. Zoonoses Public Health.

Masterproeven

Masterproef Farmaceutische Wetenschappen

Vergelijking van aanmaakmethodes van siRNA-dragers op basis van kationische liposomen voor intraveneuze applicaties. Experimenteel onderzoek aan de Faculteit Farmaceutische Wetenschappen UGent.

Promotor: Prof. dr. Apr. S. Desmet. 2007.

Masterproef ziekenhuishygiëne

INCED trial: a pharmacokinetic evaluation of cefepime administered intravenously in intensive care patients.

Promotor: Prof. dr. D. Vogelaers. 2015.